ArticleCureus2025
Knowledge, Attitudes, and Practices Related to Zoster Vaccination in Riyadh First Health Care Cluster in Saudi Arabia.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Herpes Zoster Risk in Rheumatoid Arthritis Patients on Janus Kinase Inhibitors: A 17-Year Experience from Rheumatoid Arthritis Saudi Database (RASD).Open access rheumatology : research and reviews · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundVaricella zoster vaccination plays a crucial role in preventing varicella and reducing the incidence of shingles. However, varicella zoster vaccination rates in Riyadh, Saudi Arabia, remain underexplored. This study aims to address this gap by examining the factors that influence vaccine acceptance and adherence within the Riyadh First Health Care Cluster.
objectiveThe primary aim is to assess the knowledge, attitudes, and practices (KAP) related to varicella zoster vaccination among the diverse population served by the Riyadh First Health Care Cluster. MATERIALS AND
methodsThis cross-sectional study was conducted within the Riyadh First Health Care Cluster to assess KAP related to varicella zoster vaccination. A stratified sampling method was employed to recruit a diverse group of participants from multiple healthcare facilities. The sample size was calculated to be 264 based on a 95% confidence level, 5% margin of error, and an estimated prevalence of 22%. Data were collected through face-to-face interviews using a structured and pre-tested questionnaire covering demographics and KAP. A scoring system was applied to quantify responses. Descriptive and inferential statistics, including chi-square tests and logistic regression, were used to analyze the data. Ethical approval was obtained, and informed consent was secured from all participants.
resultsThe study included 271 participants. Only 15.5% of respondents exhibited a high level of knowledge of the vaccine, while 44.3% demonstrated low knowledge, indicating a significant gap in public awareness. Despite a generally positive attitude toward vaccination, 47.6% of participants showed high acceptance, while only 18.8% reported good vaccination practices, highlighting a significant public health challenge. Notably, knowledge and attitudes were significantly related to age, gender, occupation, and income, suggesting that younger males and healthcare professionals had better awareness and acceptance.
conclusionsThe findings of this study underscore the urgent need for comprehensive public health strategies to enhance knowledge, address misconceptions, and improve vaccination uptake in Riyadh. The observed gaps in knowledge and practices, despite generally positive attitudes, highlight the importance of targeted educational initiatives that engage healthcare providers and the community.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.